145 related articles for article (PubMed ID: 3841024)
1. Enhancement of the antitumor efficacy of lomustine by the radiosensitizer RSU 1069.
Siemann DW; Alliet K; Maddison K; Wolf K
Cancer Treat Rep; 1985 Dec; 69(12):1409-14. PubMed ID: 3841024
[TBL] [Abstract][Full Text] [Related]
2. In vivo potentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea by the radiation sensitizer benznidazole.
Siemann DW; Morrissey S; Wolf K
Cancer Res; 1983 Mar; 43(3):1010-3. PubMed ID: 6825075
[TBL] [Abstract][Full Text] [Related]
3. Effect of pretreatment with phenobarbital or SKF 525A on the toxicity and antitumor activity of lomustine.
Siemann DW
Cancer Treat Rep; 1983 Mar; 67(3):259-65. PubMed ID: 6831472
[TBL] [Abstract][Full Text] [Related]
4. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
[TBL] [Abstract][Full Text] [Related]
5. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
Mulcahy RT; Siemann DW
Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
[TBL] [Abstract][Full Text] [Related]
6. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.
Siemann DW; Hill SA
Cancer Res; 1986 Feb; 46(2):629-32. PubMed ID: 3940631
[TBL] [Abstract][Full Text] [Related]
7. The chemosensitizing and cytotoxic effects of RSU 1164 and RSU 1165 in a murine tumor model.
Siemann DW
Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1115-8. PubMed ID: 2703392
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of alkylating chemotherapy by dual function nitrofurans in multi-cell spheroids and solid tumors.
Siemann DW; Sutherland RM
Radiother Oncol; 1992 Aug; 24(4):239-45. PubMed ID: 1410579
[TBL] [Abstract][Full Text] [Related]
9. Response of murine tumours to combinations of CCNU with misonidazole and other radiation sensitizers.
Siemann DW
Br J Cancer; 1982 Feb; 45(2):272-81. PubMed ID: 6460517
[TBL] [Abstract][Full Text] [Related]
10. Potentiation of combination chemotherapy by nitroheterocyclics.
Siemann DW; Allalunis-Turner MJ
Int J Radiat Oncol Biol Phys; 1988 Jul; 15(1):129-34. PubMed ID: 3391809
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of CCNU activity by misonidazole in metastases.
Siemann DW; Alliet KL
Clin Exp Metastasis; 1987; 5(1):57-63. PubMed ID: 3829497
[TBL] [Abstract][Full Text] [Related]
12. Misonidazole-induced chemopotentiation of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea toxicity in O6-methylguanine-DNA methyltransferase proficient (Mer+) and deficient (Mer-) cell lines.
Mulcahy RT
Cancer Res; 1986 Jun; 46(6):2892-7. PubMed ID: 3698015
[TBL] [Abstract][Full Text] [Related]
13. Chemopotentiation in vivo: no loss of sensitization with fractionation.
Hill SA; Siemann DW
Br J Cancer; 1984 Oct; 50(4):509-17. PubMed ID: 6487517
[TBL] [Abstract][Full Text] [Related]
14. In vivo combination of misonidazole and the chemotherapeutic agent CCNU.
Siemann DW
Br J Cancer; 1981 Mar; 43(3):367-77. PubMed ID: 7225287
[TBL] [Abstract][Full Text] [Related]
15. Potentiation of melphalan activity in the KHT sarcoma by the radiosensitizer RSU 1069.
Siemann DW; Maddison K; Wolf K
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1657-60. PubMed ID: 6548212
[TBL] [Abstract][Full Text] [Related]
16. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
Siemann DW; Hill SA
Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
[TBL] [Abstract][Full Text] [Related]
17. Schedule-dependent potentiation of lomustine cytotoxicity by amphotericin B in mice.
Valeriote F; Dieckman J; Chabot G
J Natl Cancer Inst; 1986 Mar; 76(3):521-5. PubMed ID: 3456466
[TBL] [Abstract][Full Text] [Related]
18. Effect of partition coefficient on the ability of nitroimidazoles to enhance the cytotoxicity of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.
Hirst DG; Brown JM; Hazlehurst JL
Cancer Res; 1983 May; 43(5):1961-5. PubMed ID: 6682009
[TBL] [Abstract][Full Text] [Related]
19. Oral (po) dosing with RSU 1069 or RB 6145 maintains their potency as hypoxic cell radiosensitizers and cytotoxins but reduces systemic toxicity compared with parenteral (ip) administration in mice.
Cole S; Stratford IJ; Bowler J; Nolan J; Wright EG; Lorimore SA; Adams GE
Int J Radiat Oncol Biol Phys; 1991 Jul; 21(2):387-95. PubMed ID: 2061115
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of chemotherapy and nitroimidazole-induced chemopotentiation by the vasoactive agent hydralazine.
Siemann DW
Br J Cancer; 1990 Sep; 62(3):348-53. PubMed ID: 2206941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]